Tuesday, June 13, 2017 5:20:09 PM
Discovery Harbour Resources Corp. has provided the following update on its agreements relating to the Caldera project and to the Jersey Valley project, further to its news releases dated April 4, 2017, Feb. 27, 2017, and Nov. 23, 2016.
The Caldera Project is an epithermal gold project located in Nevada, approximately 37 km from the Kinross Round Mountain Gold Mine (the "Caldera Project"). Pursuant to an Exploration License and Option to Purchase Agreement dated November 18, 2016 as amended February 17, 2017 and March 30, 2017 (collectively, the "Caldera Agreements") between the Company and Genesis Gold Corporation ("Genesis Gold"), the Company was granted a license to explore the Caldera Project and an option to acquire the same on the terms and conditions of the Caldera Agreements. Under the Caldera Agreements, the Company will receive title to the Caldera Project upon the payment by the Company to Genesis Gold of the aggregate sum of US$400,000 in advance royalty payments which are payable as follows: US$5,000 on entry into the initial Caldera Agreement (paid), US$15,000 payable on June 30, 2017, US$30,000 payable on November 18, 2017, US$50,000 payable on November 18, 2018, US$75,000 payable on November 18, 2019, US$100,000 payable on November 18, 2020 and US$125,000 payable on November 18, 2021. Genesis Gold has retained a 2% net smelter return royalty with respect to the Caldera Project. The Company will also pay rentals for the unpatented mining claims to keep the property in good standing during the term of the Caldera Agreements. The Company also issued 500,000 common share purchase warrants (collectively, the "Caldera Warrants") to Genesis Gold on June 12, 2017 pursuant to the terms of the Caldera Agreements, which Caldera Warrants are each exercisable into one common share in the capital of the Company at an exercise price of CAD$0.05 per share until June 12, 2020. The Caldera Warrants are the shares issuable upon exercise thereof are subject to a hold period expiring on October 13, 2017.
The Jersey Valley Project is an epithermal gold project located in Nevada, approximately 45km southwest of the Phoenix Deposit (Newmont Mining) and approximately 29km southwest of the Cove-McCoy Deposits (Premier Gold Mines) in the Battle Mountain mining district (the "Jersey Valley Project"). Pursuant to an Exploration License and Option to Purchase Agreement dated November 18, 2016 as amended February 17, 2017 (collectively, the "Jersey Valley Agreements") between the Company and Genesis Gold, the Company was granted a license to explore the Jersey Valley Project and an option to acquire the same on the terms and conditions of the Jersey Valley Agreements. However, as disclosed in the Company's news release dated April 3, 2017, the Company has decided to terminate the Jersey Valley Agreements so that it can focus its resources on the Caldera Project. Prior to termination, US$5,000 was paid to Genesis Gold on signing of the initial Jersey Valley Agreement. On termination, the Company's obligation to issue 100,000 common share purchase warrants (collectively, the "Jersey Valley Warrants") to Genesis Gold remained outstanding; all other payment obligations were terminated. On June 12, 2017, the Company issued the Jersey Valley Warrants to Genesis Gold, each of which is exercisable into one common share in the capital of the Company at an exercise price of CAD$0.075 per share until June 12, 2020. The Jersey Valley Warrants and the shares issuable upon exercise thereof are subject to a hold period expiring on October 13, 2017.
Recent DHR News
- Danaher Schedules Third Quarter 2024 Earnings Conference Call • PR Newswire (US) • 09/19/2024 08:30:00 PM
- Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership • PR Newswire (US) • 09/17/2024 12:30:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 09/10/2024 08:15:00 PM
- Danaher Confirms Third Quarter and Full Year 2024 Guidance • PR Newswire (US) • 09/04/2024 08:30:00 PM
- Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C. • PR Newswire (US) • 08/26/2024 09:30:00 PM
- Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration • PR Newswire (US) • 07/25/2024 01:00:00 PM
- Danaher Reports Second Quarter 2024 Results • PR Newswire (US) • 07/23/2024 10:00:00 AM
- Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development • PR Newswire (US) • 07/17/2024 11:30:00 AM
- Danaher Releases 2024 Sustainability Report • PR Newswire (US) • 07/16/2024 11:30:00 AM
- Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening • PR Newswire (US) • 07/11/2024 11:30:00 AM
- Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer • PR Newswire (US) • 07/09/2024 07:00:00 AM
- Danaher Schedules Second Quarter 2024 Earnings Conference Call • PR Newswire (US) • 06/24/2024 08:30:00 PM
- Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics • PR Newswire (US) • 06/19/2024 11:30:00 AM
- Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer • PR Newswire (US) • 06/05/2024 11:00:00 AM
- Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis • PR Newswire (US) • 05/09/2024 11:00:00 AM
- Danaher to Present at Bank of America Securities Healthcare Conference • PR Newswire (US) • 05/07/2024 08:45:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 05/07/2024 08:15:00 PM
- Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry • PR Newswire (US) • 05/03/2024 01:06:00 PM
- Danaher Reports First Quarter 2024 Results • PR Newswire (US) • 04/23/2024 10:00:00 AM
- Danaher Schedules First Quarter 2024 Earnings Conference Call • PR Newswire (US) • 03/21/2024 08:15:00 PM
- Danaher to Present at TD Cowen Health Care Conference • PR Newswire (US) • 02/27/2024 09:15:00 PM
- Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets • PR Newswire (US) • 02/22/2024 09:15:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 02/21/2024 09:15:00 PM
- Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development • PR Newswire (US) • 02/05/2024 12:30:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM